Search

Search Constraints

You searched for: Author/Creator Grande, Enrique

Search Results

1. 177Lu-Dotatate plus long-acting octreotide versus high‑dose long-acting octreotide in patients with midgut neuroendocrine tumours (NETTER-1): final overall survival and long-term safety results from an open-label, randomised, controlled, phase 3 trial. Issue 12 (December 2021)

2. A correlative biomarker study and integrative prognostic model in chemotherapy‐naïve metastatic castration‐resistant prostate cancer treated with enzalutamide. Issue 4 (23rd December 2022)

5. Atezolizumab with or without chemotherapy in metastatic urothelial cancer (IMvigor130): a multicentre, randomised, placebo-controlled phase 3 trial. Issue 10236 (16th May 2020)

6. Axitinib treatment in advanced RAI-resistant differentiated thyroid cancer (DTC) and refractory medullary thyroid cancer (MTC). Issue 4 (October 2017)

7. Capecitabine and temozolomide in grade 1/2 neuroendocrine tumors: a Spanish multicenter experience. (March 2017)

9. Economics of gastroenteropancreatic neuroendocrine tumors: a systematic review. (February 2019)